Search research articles
Contact Us
Filters
Showing results (131-140 of 186) with videos related to
Page
of 19
Sort By:
Nature Genetics
|
July 25, 2022
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, et al.
Science (New York, N.Y.)
|
May 9, 2015
Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion
Elizabeth S Egan, Rays H Y Jiang, Mischka A Moechtar, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Proteome-wide base editor screens to assess phosphorylation site functionality in high-throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature Genetics
|
December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers
Takahiro Ito, Michael J Young, Ruitong Li, et al.
Plos Biology
|
June 13, 2023
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
Madison S Strine, Wesley L Cai, Jin Wei, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seq
Kathryn Geiger-Schuller, Basak Eraslan, Olena Kuksenko, et al.
Nature Communications
|
April 10, 2019
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Yilong Zou, Michael J Palte, Amy A Deik, et al.
Nature Methods
|
April 29, 2024
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature
|
July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Cancer Discovery
|
March 12, 2021
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Sushil Kumar, Zexian Zeng, Archis Bagati, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 186) with videos related to
Sort By:
Page
of 19
Nature Genetics
|
July 25, 2022
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, et al.
Science (New York, N.Y.)
|
May 9, 2015
Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion
Elizabeth S Egan, Rays H Y Jiang, Mischka A Moechtar, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Proteome-wide base editor screens to assess phosphorylation site functionality in high-throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature Genetics
|
December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers
Takahiro Ito, Michael J Young, Ruitong Li, et al.
Plos Biology
|
June 13, 2023
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
Madison S Strine, Wesley L Cai, Jin Wei, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seq
Kathryn Geiger-Schuller, Basak Eraslan, Olena Kuksenko, et al.
Nature Communications
|
April 10, 2019
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
Yilong Zou, Michael J Palte, Amy A Deik, et al.
Nature Methods
|
April 29, 2024
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature
|
July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Cancer Discovery
|
March 12, 2021
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Sushil Kumar, Zexian Zeng, Archis Bagati, et al.
Page
of 19